bf/NASDAQ:PRQR_icon.png

COM:PROQR

ProQR Therapeutics

  • Stock

Last Close

3.61

22/11 21:00

Market Cap

295.62M

Beta: -

Volume Today

390.09K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
313K
-
9.41M
2,905.43%
2.28M
75.74%
-1.53M
167.00%
4.94M
423.15%
1.93M
60.88%
1.35M
-
4.04M
198.15%
6.38M
58.05%
cost of revenue
116.82M
-
gross profit
313K
-
9.41M
2,905.43%
2.28M
75.74%
-1.53M
167.00%
4.94M
423.15%
-114.89M
2,425.24%
1.35M
-
4.04M
198.15%
6.38M
58.05%
selling and marketing expenses
-841.17K
-
general and administrative expenses
786K
-
6.51M
727.86%
6.84M
5.07%
9.48M
38.63%
10.84M
14.37%
12.54M
15.68%
12.89M
2.77%
13.69M
6.19%
17.37M
26.91%
18.65M
7.39%
16.24M
12.95%
selling general and administrative expenses
786K
-
6.51M
727.86%
6.84M
5.07%
9.48M
38.63%
10.84M
14.37%
12.54M
15.68%
12.89M
2.77%
13.69M
6.19%
17.37M
26.91%
18.65M
7.39%
15.39M
17.46%
research and development expenses
2.57M
-
10.27M
299.65%
23.40M
127.92%
31.92M
36.42%
31.15M
2.41%
29.51M
5.26%
46.49M
57.52%
38.13M
17.97%
42.22M
10.71%
50.87M
20.48%
22.68M
55.41%
other expenses
313K
-
3.23M
933.55%
1.83M
43.49%
1.50M
18.22%
5.76M
285.35%
1.93M
66.45%
9.37M
384.64%
-1.04M
111.13%
-765K
26.65%
953K
224.58%
cost and expenses
3.24M
-
16.77M
417.88%
30.24M
80.27%
41.40M
36.92%
41.99M
1.43%
42.05M
0.15%
59.38M
41.19%
51.82M
12.73%
58.55M
12.98%
68.75M
17.44%
40.54M
41.04%
operating expenses
3.24M
-
16.77M
417.88%
30.24M
80.27%
41.40M
36.92%
41.99M
1.43%
42.05M
0.15%
59.38M
41.19%
51.82M
12.73%
58.55M
12.98%
68.75M
17.44%
38.07M
44.62%
interest expense
38K
-
265K
597.37%
395K
49.06%
538K
36.20%
596K
10.78%
810K
35.91%
1.08M
33.70%
2.04M
88.37%
3.40M
66.91%
5.13M
50.57%
1.15M
77.61%
ebitda
-3.19M
-
-16.65M
421.72%
-29.76M
78.75%
-40.16M
34.94%
-40.93M
1.92%
-41.06M
0.33%
-57.33M
39.61%
-49.47M
13.71%
-55.38M
11.95%
-59.38M
7.24%
-31.69M
46.63%
operating income
-3.24M
-
-16.46M
408.21%
-27.00M
64.04%
-39.57M
46.55%
-40.50M
2.34%
-36.29M
10.38%
-57.45M
58.28%
-42.37M
26.25%
-57.19M
34.99%
-64.72M
13.16%
-34.16M
47.22%
depreciation and amortization
24K
-
126K
425%
480K
280.95%
1.25M
159.38%
1.06M
14.46%
992K
6.85%
119K
88.00%
-7.10M
6,063.87%
1.81M
125.57%
5.33M
193.77%
2.46M
53.84%
total other income expenses net
-14K
-
313K
2,335.71%
3.23M
933.55%
1.83M
43.49%
1.50M
18.22%
5.76M
285.35%
831K
85.58%
-4.12M
596.03%
-4.37M
6.07%
-79K
98.19%
6.91M
8,849.80%
income before tax
-3.25M
-
-12.13M
272.79%
-20.83M
71.78%
-39.10M
87.71%
-43.67M
11.69%
-37.09M
15.08%
-56.61M
52.66%
-46.49M
17.88%
-61.56M
32.42%
-64.80M
5.25%
-27.24M
57.96%
income tax expense
24K
-
-4.33M
18,158.33%
-6.17M
42.39%
-470K
92.38%
2K
100.43%
1K
50%
132K
13,100%
124K
6.06%
117K
5.65%
96K
17.95%
-76.40K
179.58%
net income
-3.25M
-
-12.13M
272.79%
-20.83M
71.78%
-39.10M
87.71%
-43.64M
11.60%
-36.89M
15.45%
-56.75M
53.81%
-46.61M
17.86%
-61.68M
32.32%
-64.89M
5.21%
-27.54M
57.56%
weighted average shs out
22.21M
-
11.08M
50.11%
23.34M
110.63%
23.35M
0.01%
25.37M
8.69%
34.05M
34.20%
41.04M
20.51%
50.06M
21.99%
64.18M
28.21%
71.64M
11.62%
81.01M
13.08%
weighted average shs out dil
22.21M
-
11.08M
50.11%
23.34M
110.63%
23.35M
0.01%
25.37M
8.69%
34.05M
34.20%
41.04M
20.51%
50.06M
21.99%
64.18M
28.21%
71.64M
11.62%
81.01M
13.08%
eps
-0.15
-
-1.09
626.67%
-0.89
18.35%
-1.67
87.64%
-1.72
2.99%
-1.08
37.21%
-1.38
27.78%
-0.93
32.61%
-0.96
3.23%
-0.91
5.21%
-0.34
62.64%
epsdiluted
-0.15
-
-1.09
626.67%
-0.89
18.35%
-1.67
87.64%
-1.72
2.99%
-1.08
37.21%
-1.38
27.78%
-0.93
32.61%
-0.96
3.23%
-0.91
5.21%
-0.34
62.64%

All numbers in (except ratios and percentages)